Goals & Strategies

Overarching goals

•  To create long-term value for Genovis’ shareholders.
•  To become one of the world-leading players in the market for nanostructures as
contrast agents in biomedical imaging.

Goals for 2011 and 2012

•  To substantially increase sales of products from the protein engineering portfolio in
the markets in Europe and the United States, and to establish the products in the Asian market.
•  To launch nanostructures for preclinical imaging and to establish
sales via partners.
•  To demonstrate proof-of-concept in the Sentinel node R&D project.

Strategy

In order to achieve the established goals in both the long and short term, Genovis will build a cost-effective internal sales organization that works with focused customer support in teams with partners and distributors. Genovis will also foster strong, efficient and creative product development, focusing on products that strengthen the customer's business model. By working close to the frontlines of research and by actively seeking new techniques through the acquisition of intellectual property or other innovative companies, Genovis will also over the long term be able to offer its customers innovations within both product groups.